Categories Investing
Categories Investing
Teck Greenlights Highland Valley Expansion After Beating Q2 Profit Estimates
July 26, 2025
Teck Resources (TSX:TECK.A,TSX:TECK.B,NYSE:TECK) has secured board approval for a multi-billion-dollar life extension of its Highland Valley copper mine in British Columbia, setting
Categories Investing
Pinnacle Increases Non-Brokered Private Placement
July 26, 2025
(TheNewswire) The net proceeds raised from the Offering will be used to advance the high-grade El Potrero gold-silver project in
Categories Investing
Editor’s Picks: Miners Rescued, US Mine Waste Strategy, Ontario Expands CIMF
July 26, 2025
Here’s a quick recap of some of the most impactful resource sector news items for the week. The period saw three miners rescued
Categories Investing
Top 5 Canadian Mining Stocks This Week: St. Augustine Gains 67 Percent
July 26, 2025
Statistics Canada released its monthly mineral production report for May 2025 on Monday (July 21). The data shows that the production of
Categories Stock
Chart Mania – 23 ATR Move in QQQ – Metals Lead 2025 – XLV Oversold – XLU Breakout – ITB Moment of Truth
July 26, 2025
Here are some charts that reflect our areas of focus this week at XLU Leads with New High Even though the Utilities SPDR
Categories Business
Microsoft’s Satya Nadella says job cuts have been ‘weighing heavily’ on him
July 26, 2025
Microsoft has laid off over 15,000 people so far in 2025. The stress of the belt-tightening has gotten to CEO Satya Nadella. “Before
Categories Business
FCC greenlights Paramount’s $8 billion merger with entertainment group Skydance
July 26, 2025
Trump administration regulators have approved Skydance Media’s $8 billion bid to acquire CBS News parent company Paramount, paving the way for a
Categories Investing
Top 5 Canadian Biotech Stocks of 2025
July 25, 2025
Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector is home to
Categories Investing
Biotech and Pharma Market Update: Q2 2025 in Review
July 25, 2025
The second quarter of 2025 was a period of dynamic evolution within the biotechnology and pharmaceutical sectors. Critical factors like escalating policy